跳至主要内容
临床试验/NCT00706290
NCT00706290已完成2 期

Brief CBT for Anxiety and Advanced Cancer

Massachusetts General Hospital2 个研究点 分布在 1 个国家目标入组 49 人开始时间: 2007年4月最近更新:
适应症

试验速览

阶段
2 期
状态
已完成
入组人数
49
试验地点
2
主要终点
Anxiety symptoms as measured by the Hamilton Anxiety Rating Scale

研究概览

简要总结

RATIONALE: Providing cognitive-behavioral therapy (CBT) may reduce anxiety and improve quality of life of patients with advanced cancer.

PURPOSE: To examine the development and pilot testing of a brief cognitive-behavioral therapy intervention to treat anxiety and improve quality of life in patients with advanced cancer.

Hypothesis: Patients with anxiety associated with advanced cancer who receive CBT will report significantly fewer anxiety symptoms compared to those in the comparison condition.

详细描述

OBJECTIVES:

  • To develop and examine the feasibility and patient acceptability of administering a manualized cognitive-behavioral intervention that improves quality of life by treating anxiety in patients with advanced cancer.
  • To estimate the effect size of a manualized cognitive-behavioral intervention to reduce anxiety in patients with advanced cancer.
  • To estimate the effect size for the secondary outcomes (i.e., depression and quality of life) and to examine the extent to which specific variables (i.e., sex, age, chemotherapy side effects, pain levels) are consistent with the conceptual model as potential moderators of treatment effect.

OUTLINE: This is a pilot study followed by a randomized study. Patients are stratified according to type of cancer.

  • Pilot study: Patients complete qualitative interviews to explore ways that anxiety impacts patients, to identify components of a cognitive-behavioral therapy intervention that are most useful, and to determine the optimal method of delivery for the intervention (e.g., number and timing of interventions, administration during chemotherapy infusions when feasible). Based upon these results a full treatment manual is written for use in the randomized study.

Patients are then randomized to 1 of 2 treatment arms.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Single (Outcomes Assessor)

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • 未提供

排除标准

  • 未提供

结局指标

主要结局

Anxiety symptoms as measured by the Hamilton Anxiety Rating Scale

时间窗: 1) At enrollment pre-intervention. 2) Post intervention (2-3 months after enrollment)

The Hamilton Anxiety Ratings Scale (HAM-A) consists of 14 items that provide an overall measure of global anxiety.

次要结局

  • Depression as measured by the Montgomery Asberg Depression Rating Scale(1) At enrollment pre-intervention. 2) Post intervention (2-3 months after enrollment))
  • Quality of life as measured by the Functional Assessment of Scale Cancer Therapy (FACT-G)(1) At enrollment pre-intervention. 2) Post intervention (2-3 months after enrollment))

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Joseph A. Greer, Ph.D.

Clinical Assistant in Psychology

Massachusetts General Hospital

研究点 (2)

Loading locations...

相似试验